Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Illumina Inc (NQ: ILMN )

449.88 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9
Open 449.88
Bid (Size) 441.00 (3)
Ask (Size) 476.00 (1)
Prev. Close 449.88
Today's Range 449.88 - 449.88
52wk Range 260.42 - 555.77
Shares Outstanding 146,700,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Illumina Accelerator Invests in Seven Genomics Startups for Third Global Cycle
Diverse investments from Israel, Mexico, Poland, South Africa, United Kingdom and United States 
From PR Newswire
Illumina Accelerator Invests in Seven Genomics Startups for Third Global Cycle
Tags Health & Healthcare Illumina For Startups NASDAQ: ILMN
From 3BL Media: Corporate Social Responsibility, Energy and Health News

Performance

YTD
+22.33%
+22.33%
1 Month
-14.28%
-14.28%
3 Month
+1.00%
+1.00%
6 Month
+7.08%
+7.08%
1 Year
+27.74%
+27.74%

More News

Read More
Dante Labs Announces Expansion of its Finance Team with the Appointment of Andre Nel as Chief Financial Officer, Dalila Rahmani as Chief Accounting Officer, Laura D’Angelo as VP Investor Relations and
From GlobeNewswire News Releases
Illumina Commits to Net Zero Global Greenhouse Gas Emissions by 2050
From PR Newswire
Illumina Commits to Net Zero Global Greenhouse Gas Emissions by 2050
Tags illumina Environment NASDAQ:ILM
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Illumina Partners with Merck to Develop and Commercialize Companion Diagnostic and Research Tests for Use in Identifying Specific Cancer Mutations
From PR Newswire
Illumina To Webcast Upcoming Investor Conference
From PR Newswire
INVESTOR ALERT. An Investor Investigation Is Underway Regarding Illumina’s Closing of Its GRAIL Acquisition Without Obtaining EU Approval
From GlobeNewswire News Releases
UK's NHS Launches World's Largest Trial Of Blood Test For 50 Types
Tags General Health Care Market News
From Benzinga
3 Crash-Ready Stocks to Buy in September
Tags EXAS GH CRSP
From Motley Fool
Illumina, Merck Join Hands For Homologous Recombination Deficiency CDx, Research Assay
Tags Health Care Market News Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.